Cargando…

The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy

BACKGROUND AND PURPOSE: The derived neutrophil–lymphocyte ratio (dNLR) is a validated prognostic biomarker for cancer survival but has not been extensively studied in locally-advanced oesophageal cancer treated with definitive chemoradiotherapy (dCRT). We aimed to identify the prognostic value of dN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, Samantha, Hurt, Christopher, Grenader, Tal, Mukherjee, Somnath, Bridgewater, John, Crosby, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648078/ https://www.ncbi.nlm.nih.gov/pubmed/28893415 http://dx.doi.org/10.1016/j.radonc.2017.08.023

Ejemplares similares

Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1
por: Cox, S, et al.
Publicado: (2016)

Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma
por: Zhang, Guojun, et al.
Publicado: (2023)

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors
por: Grenader, Tal, et al.
Publicado: (2020)

Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy
por: Li, Ke-Jie, et al.
Publicado: (2019)

Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio
por: Lee, Soo Jin, et al.
Publicado: (2022)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
por: Crosby, T, et al.
Publicado: (2017)

Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study
por: Grenader, Tal, et al.
Publicado: (2016)

The Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy
por: Young, Caroline A, et al.
Publicado: (2014)

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
por: Zhou, Xi-Lei, et al.
Publicado: (2017)

Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
por: Blazeby, J M, et al.
Publicado: (2014)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
por: Zhang, Yan, et al.
Publicado: (2018)

Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer
por: Lee, Jeong Won, et al.
Publicado: (2021)

The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy
por: Lee, Byung Min, et al.
Publicado: (2018)

Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Park, Eun Young, et al.
Publicado: (2019)

Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer
por: Chen, Jie, et al.
Publicado: (2015)

Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
por: Howard, Rachel, et al.
Publicado: (2019)

The Role of Pretreatment Serum Neutrophil-to-Lymphocyte Ratio in Hypopharyngeal Cancer Treated with Definitive Chemoradiotherapy: A Pilot Study
por: Kuo, Chin, et al.
Publicado: (2019)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer
por: Tougeron, D, et al.
Publicado: (2008)

Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy
por: Song, Xinyu, et al.
Publicado: (2018)

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
por: Shen, Jinwen, et al.
Publicado: (2017)

Prognostic Significance of the Post-Treatment Neutrophil-to-Lymphocyte Ratio in Pharyngeal Cancers Treated with Concurrent Chemoradiotherapy
por: Yun, Ji Min, et al.
Publicado: (2023)

The diagnostic and prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on gastric cancer patients
por: Nguyen, Mai Ly Thi, et al.
Publicado: (2023)

Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn’s disease
por: Argeny, Stanislaus, et al.
Publicado: (2018)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer
por: Ribnikar, Domen, et al.
Publicado: (2020)

Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Cats With Hypertrophic Cardiomyopathy
por: Fries, Ryan C., et al.
Publicado: (2022)

The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer
por: Wang, Liqun, et al.
Publicado: (2017)

Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas
por: Cox, Samantha J., et al.
Publicado: (2017)

Total Lymphocyte Count, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio as Prognostic Factors in Advanced Non-Small Cell Lung Cancer with Chemoradiotherapy [Corrigenudm]
Publicado: (2021)

Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma
por: Jeong, Hyehyun, et al.
Publicado: (2021)

Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis
por: Liao, Jiaxian, et al.
Publicado: (2022)

Prognostic Value of Platelet to Lymphocyte Ratio (PLR) and Neutrophil to Lymphocyte Ratio (NLR) in Patients with Pulmonary Hypertension
por: Shahmoradi, Zahra, et al.
Publicado: (2022)

Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer
por: Hsu, Jun-Te, et al.
Publicado: (2015)

Prognostic Value of Preoperative Neutrophil-to-lymphocyte Ratio for Prediction of Severe Cholecystitis
por: Micić, Dušan, et al.
Publicado: (2018)

Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases
por: Ozyurek, Berna Akinci, et al.
Publicado: (2017)

Predictive prognostic value of neutrophil–lymphocytes ratio in acute coronary syndrome
por: Bajari, Rajesh, et al.
Publicado: (2017)

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Pediatric Parotid Cancer
por: Seng, Dongjie, et al.
Publicado: (2019)

Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
por: Abu Omar, Yazan, et al.
Publicado: (2019)

Prognostic value of the neutrophil-to-lymphocyte ratio in acute organophosphorus pesticide poisoning
por: Mu, Yuhang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mpltbsjdmqlrddneo0lucjvlk8